1st Quarter - Report
KEANEY CONSULTING INC. for ACAMBIS INC
Client
Income
$12,926
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Met with Hill staff to discuss: (1.) Acambis new FDA licensed second generation smallpox vaccine and the relocation of vaccine production facilities to the US; (2.) the status of vaccine doses in the HHS/CDC stockpile; (3.) the status of the CDC negotiations on their smallpox contract and (4.) the timing and future funding needs for Federal vaccine purchases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID - KEANEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.